Callan Family Office LLC Makes New $572,000 Investment in The Cooper Companies, Inc. $COO

Callan Family Office LLC acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, Holdings Channel reports. The fund acquired 7,974 shares of the medical device company’s stock, valued at approximately $572,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in Cooper Companies in the 2nd quarter valued at $1,077,762,000. Generation Investment Management LLP acquired a new position in Cooper Companies during the second quarter worth $356,304,000. Wellington Management Group LLP lifted its stake in shares of Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after buying an additional 4,756,178 shares in the last quarter. Diamond Hill Capital Management Inc. lifted its stake in shares of Cooper Companies by 479.6% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after buying an additional 2,720,594 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after buying an additional 2,231,568 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Traders purchased 4,056 call options on COO, roughly 411% above the typical daily volume of 794 contracts. This points to increased speculative bullish interest, although options activity alone does not guarantee a sustained stock advance.
• Neutral Sentiment: The latest short-interest report lists zero shares sold short and a 0.0-day short-interest ratio, but it also describes the change as “NaN” from a prior total of zero. The figures appear inconsistent and provide little useful information about investor positioning. Short Interest Report
• Negative Sentiment: COO’s valuation remains demanding, with a reported P/E ratio near 62. That can make the shares more sensitive to profit-taking or a lack of fresh positive catalysts, even though the company recently exceeded quarterly earnings and revenue expectations and reported year-over-year revenue growth.

Wall Street Analyst Weigh In

COO has been the subject of several recent research reports. Wells Fargo & Company reissued a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. JPMorgan Chase & Co. cut their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Finally, Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Stock Performance

Shares of COO stock opened at $73.04 on Wednesday. The firm has a 50-day moving average of $72.20 and a 200-day moving average of $71.01. The company has a market cap of $14.24 billion, a P/E ratio of 61.90, a P/E/G ratio of 1.98 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period last year, the firm earned $0.96 earnings per share. The firm’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.